{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:10:46Z","timestamp":1776730246470,"version":"3.51.2"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,3,17]],"date-time":"2017-03-17T00:00:00Z","timestamp":1489708800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Cardiol Rep"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1007\/s11886-017-0842-1","type":"journal-article","created":{"date-parts":[[2017,3,17]],"date-time":"2017-03-17T08:12:18Z","timestamp":1489738338000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Untangling the Biology of Genetic Cardiomyopathies with Pluripotent Stem Cell Disease Models"],"prefix":"10.1007","volume":"19","author":[{"given":"Jan W.","family":"Buikema","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean M.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,3,17]]},"reference":[{"issue":"41","key":"842_CR1","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1093\/eurheartj\/ehv316","volume":"36","author":"SG Priori","year":"2015","unstructured":"Priori SG, Blomstrom-Lundqvist C, Mazzanti A, et al. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: the Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J. 2015;36(41):2793\u2013867.","journal-title":"Eur Heart J"},{"issue":"11","key":"842_CR2","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/nrg1710","volume":"6","author":"M Buckingham","year":"2005","unstructured":"Buckingham M, Meilhac S, Zaffran S. Building the mammalian heart from two sources of myocardial cells. Nat Rev Genet. 2005;6(11):826\u201335.","journal-title":"Nat Rev Genet"},{"issue":"6","key":"842_CR3","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1161\/CIRCRESAHA.113.259259","volume":"112","author":"S Gregoire","year":"2013","unstructured":"Gregoire S, Karra R, Passer D, et al. Essential and unexpected role of Yin Yang 1 to promote mesodermal cardiac differentiation. Circ Res. 2013;112(6):900\u201310.","journal-title":"Circ Res"},{"issue":"6","key":"842_CR4","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.cell.2006.10.028","volume":"127","author":"SM Wu","year":"2006","unstructured":"Wu SM, Fujiwara Y, Cibulsky SM, et al. Developmental origin of a bipotential myocardial and smooth muscle cell precursor in the mammalian heart. Cell. 2006;127(6):1137\u201350.","journal-title":"Cell"},{"issue":"7","key":"842_CR5","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1016\/j.celrep.2016.01.030","volume":"14","author":"D Passer","year":"2016","unstructured":"Passer D, van de Vrugt A, Atmanli A, et al. Atypical protein kinase C-dependent polarized cell division is required for myocardial trabeculation. Cell Rep. 2016;14(7):1662\u201372.","journal-title":"Cell Rep"},{"key":"842_CR6","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/0471143030.cb2309s61","volume":"61","author":"JW Buikema","year":"2013","unstructured":"Buikema JW, Zwetsloot PP, Doevendans PA, et al. Expanding mouse ventricular cardiomyocytes through GSK-3 inhibition. Curr Protoc Cell Biol. 2013;61:23.","journal-title":"Curr Protoc Cell Biol"},{"issue":"20","key":"842_CR7","doi-asserted-by":"crossref","first-page":"4165","DOI":"10.1242\/dev.099325","volume":"140","author":"JW Buikema","year":"2013","unstructured":"Buikema JW, Mady AS, Mittal NV, et al. Wnt\/beta-catenin signaling directs the regional expansion of first and second heart field-derived ventricular cardiomyocytes. Development. 2013;140(20):4165\u201376.","journal-title":"Development"},{"issue":"4","key":"842_CR8","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1152\/physrev.00006.2003","volume":"83","author":"AF Moorman","year":"2003","unstructured":"Moorman AF, Christoffels VM. Cardiac chamber formation: development, genes, and evolution. Physiol Rev. 2003;83(4):1223\u201367.","journal-title":"Physiol Rev"},{"issue":"6028","key":"842_CR9","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1126\/science.1199010","volume":"332","author":"T Heallen","year":"2011","unstructured":"Heallen T, Zhang M, Wang J, et al. Hippo pathway inhibits Wnt signaling to restrain cardiomyocyte proliferation and heart size. Science. 2011;332(6028):458\u201361.","journal-title":"Science"},{"issue":"7448","key":"842_CR10","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nature12054","volume":"497","author":"AI Mahmoud","year":"2013","unstructured":"Mahmoud AI, Kocabas F, Muralidhar SA, et al. Meis1 regulates postnatal cardiomyocyte cell cycle arrest. Nature. 2013;497(7448):249\u201353.","journal-title":"Nature"},{"issue":"1","key":"842_CR11","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1136\/adc.55.1.7","volume":"55","author":"DP Southall","year":"1980","unstructured":"Southall DP, Richards J, Brown DJ, et al. 24-hour tape recordings of ECG and respiration in the newborn infant with findings related to sudden death and unexplained brain damage in infancy. Arch Dis Child. 1980;55(1):7\u201316.","journal-title":"Arch Dis Child"},{"issue":"12","key":"842_CR12","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1038\/nrg2700","volume":"10","author":"JC Izpisua Belmonte","year":"2009","unstructured":"Izpisua Belmonte JC, Ellis J, Hochedlinger K, et al. Induced pluripotent stem cells and reprogramming: seeing the science through the hype. Nat Rev Genet. 2009;10(12):878\u201383.","journal-title":"Nat Rev Genet"},{"issue":"5","key":"842_CR13","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","volume":"131","author":"K Takahashi","year":"2007","unstructured":"Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131(5):861\u201372.","journal-title":"Cell"},{"issue":"18","key":"842_CR14","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/j.jacc.2016.01.083","volume":"67","author":"N Sayed","year":"2016","unstructured":"Sayed N, Liu C, Wu JC. Translation of human-induced pluripotent stem cells: from clinical trial in a dish to precision medicine. J Am Coll Cardiol. 2016;67(18):2161\u201376.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"842_CR15","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/embj.201387098","volume":"33","author":"H Inoue","year":"2014","unstructured":"Inoue H, Nagata N, Kurokawa H, et al. iPS cells: a game changer for future medicine. EMBO J. 2014;33(5):409\u201317.","journal-title":"EMBO J"},{"issue":"10","key":"842_CR16","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1038\/ncb3411","volume":"18","author":"K Kodo","year":"2016","unstructured":"\u2022 Kodo K, Ong SG, Jahanbani F, et al. iPSC-derived cardiomyocytes reveal abnormal TGF-beta signalling in left ventricular non-compaction cardiomyopathy. Nat Cell Biol. 2016;18(10):1031\u201342. This work uncovered a novel underlying mechanism of a poorly understood cardiomyopathy as LVNC.","journal-title":"Nat Cell Biol"},{"issue":"2","key":"842_CR17","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/cvr\/cvu205","volume":"104","author":"L Han","year":"2014","unstructured":"Han L, Li Y, Tchao J, et al. Study familial hypertrophic cardiomyopathy using patient-specific induced pluripotent stem cells. Cardiovasc Res. 2014;104(2):258\u201369.","journal-title":"Cardiovasc Res"},{"issue":"1","key":"842_CR18","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.stem.2012.10.010","volume":"12","author":"F Lan","year":"2013","unstructured":"\u2022\u2022 Lan F, Lee AS, Liang P, et al. Abnormal calcium handling properties underlie familial hypertrophic cardiomyopathy pathology in patient-specific induced pluripotent stem cells. Cell Stem Cell. 2013;12(1):101\u201313. First study utilizing a human HCM disease model to provide direct evidence of elevation in calcium levels as an initiating factor in the development of hypertrophy at the single-cell level.","journal-title":"Cell Stem Cell"},{"issue":"6","key":"842_CR19","doi-asserted-by":"crossref","first-page":"e001263","DOI":"10.1161\/JAHA.114.001263","volume":"3","author":"A Tanaka","year":"2014","unstructured":"Tanaka A, Yuasa S, Mearini G, et al. Endothelin-1 induces myofibrillar disarray and contractile vector variability in hypertrophic cardiomyopathy-induced pluripotent stem cell-derived cardiomyocytes. J Am Heart Assoc. 2014;3(6):e001263.","journal-title":"J Am Heart Assoc"},{"issue":"130","key":"842_CR20","first-page":"130ra47","volume":"4","author":"N Sun","year":"2012","unstructured":"Sun N, Yazawa M, Liu J, et al. Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy. Sci Transl Med. 2012;4(130):130ra47.","journal-title":"Sci Transl Med"},{"key":"842_CR21","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/7651_2015_196","volume":"1353","author":"PW Burridge","year":"2016","unstructured":"Burridge PW, Diecke S, Matsa E, et al. Modeling cardiovascular diseases with patient-specific human pluripotent stem cell-derived cardiomyocytes. Methods Mol Biol. 2016;1353:119\u201330.","journal-title":"Methods Mol Biol"},{"issue":"7","key":"842_CR22","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1093\/hmg\/dds556","volume":"22","author":"HF Tse","year":"2013","unstructured":"Tse HF, Ho JC, Choi SW, et al. Patient-specific induced-pluripotent stem cells-derived cardiomyocytes recapitulate the pathogenic phenotypes of dilated cardiomyopathy due to a novel DES mutation identified by whole exome sequencing. Hum Mol Genet. 2013;22(7):1395\u2013403.","journal-title":"Hum Mol Genet"},{"issue":"6251","key":"842_CR23","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1126\/science.aaa5458","volume":"349","author":"JT Hinson","year":"2015","unstructured":"Hinson JT, Chopra A, Nafissi N, et al. HEART DISEASE. Titin mutations in iPS cells define sarcomere insufficiency as a cause of dilated cardiomyopathy. Science. 2015;349(6251):982\u20136.","journal-title":"Science"},{"issue":"15","key":"842_CR24","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1093\/eurheartj\/ehs226","volume":"34","author":"D Ma","year":"2013","unstructured":"Ma D, Wei H, Lu J, et al. Generation of patient-specific induced pluripotent stem cell-derived cardiomyocytes as a cellular model of arrhythmogenic right ventricular cardiomyopathy. Eur Heart J. 2013;34(15):1122\u201333.","journal-title":"Eur Heart J"},{"issue":"6","key":"842_CR25","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1161\/CIRCGENETICS.113.000188","volume":"6","author":"O Caspi","year":"2013","unstructured":"Caspi O, Huber I, Gepstein A, et al. Modeling of arrhythmogenic right ventricular cardiomyopathy with human induced pluripotent stem cells. Circ Cardiovasc Genet. 2013;6(6):557\u201368.","journal-title":"Circ Cardiovasc Genet"},{"issue":"7435","key":"842_CR26","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nature11799","volume":"494","author":"C Kim","year":"2013","unstructured":"Kim C, Wong J, Wen J, et al. Studying arrhythmogenic right ventricular dysplasia with patient-specific iPSCs. Nature. 2013;494(7435):105\u201310.","journal-title":"Nature"},{"issue":"2","key":"842_CR27","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1161\/01.CIR.82.2.507","volume":"82","author":"TK Chin","year":"1990","unstructured":"Chin TK, Perloff JK, Williams RG, et al. Isolated noncompaction of left ventricular myocardium. A study of eight cases. Circulation. 1990;82(2):507\u201313.","journal-title":"Circulation"},{"issue":"6","key":"842_CR28","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.amjcard.2016.06.033","volume":"118","author":"R Ronderos","year":"2016","unstructured":"Ronderos R, Avegliano G, Borelli E, et al. Estimation of prevalence of the left ventricular noncompaction among adults. Am J Cardiol. 2016;118(6):901\u20135.","journal-title":"Am J Cardiol"},{"issue":"2","key":"842_CR29","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nm.3046","volume":"19","author":"G Luxan","year":"2013","unstructured":"Luxan G, Casanova JC, Martinez-Poveda B, et al. Mutations in the NOTCH pathway regulator MIB1 cause left ventricular noncompaction cardiomyopathy. Nat Med. 2013;19(2):193\u2013201.","journal-title":"Nat Med"},{"issue":"9","key":"842_CR30","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.jacc.2016.05.096","volume":"68","author":"E Arbustini","year":"2016","unstructured":"Arbustini E, Favalli V, Narula N, et al. Left ventricular noncompaction: a distinct genetic cardiomyopathy? J Am Coll Cardiol. 2016;68(9):949\u201366.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"842_CR31","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/s00380-014-0503-x","volume":"30","author":"T Tian","year":"2015","unstructured":"Tian T, Wang J, Wang H, et al. A low prevalence of sarcomeric gene variants in a Chinese cohort with left ventricular non-compaction. Heart Vessels. 2015;30(2):258\u201364.","journal-title":"Heart Vessels"},{"issue":"12","key":"842_CR32","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jacc.2015.01.019","volume":"65","author":"C Semsarian","year":"2015","unstructured":"Semsarian C, Ingles J, Maron MS, et al. New perspectives on the prevalence of hypertrophic cardiomyopathy. J Am Coll Cardiol. 2015;65(12):1249\u201354.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"842_CR33","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0167-4838(93)90038-S","volume":"1203","author":"S Alagiri","year":"1993","unstructured":"Alagiri S, Singh TP. Stability and kinetics of a bifunctional amylase\/trypsin inhibitor. Biochim Biophys Acta. 1993;1203(1):77\u201384.","journal-title":"Biochim Biophys Acta"},{"issue":"8","key":"842_CR34","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.jacc.2012.02.068","volume":"60","author":"BJ Maron","year":"2012","unstructured":"Maron BJ, Maron MS, Semsarian C. Genetics of hypertrophic cardiomyopathy after 20 years: clinical perspectives. J Am Coll Cardiol. 2012;60(8):705\u201315.","journal-title":"J Am Coll Cardiol"},{"issue":"13","key":"842_CR35","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1056\/NEJM198703263161305","volume":"316","author":"BJ Maron","year":"1987","unstructured":"Maron BJ, Bonow RO, Cannon III RO, et al. Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy (1). N Engl J Med. 1987;316(13):780\u20139.","journal-title":"N Engl J Med"},{"issue":"3","key":"842_CR36","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jacc.2009.05.006","volume":"54","author":"MS Maron","year":"2009","unstructured":"Maron MS, Maron BJ, Harrigan C, et al. Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance. J Am Coll Cardiol. 2009;54(3):220\u20138.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"842_CR37","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.gene.2015.11.048","volume":"577","author":"I Bottillo","year":"2016","unstructured":"Bottillo I, D\u2019Angelantonio D, Caputo V, et al. Molecular analysis of sarcomeric and non-sarcomeric genes in patients with hypertrophic cardiomyopathy. Gene. 2016;577(2):227\u201335.","journal-title":"Gene"},{"issue":"11","key":"842_CR38","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1161\/CIRCRESAHA.111.300436","volume":"112","author":"V Sequeira","year":"2013","unstructured":"Sequeira V, Wijnker PJ, Nijenkamp LL, et al. Perturbed length-dependent activation in human hypertrophic cardiomyopathy with missense sarcomeric gene mutations. Circ Res. 2013;112(11):1491\u2013505.","journal-title":"Circ Res"},{"issue":"24","key":"842_CR39","doi-asserted-by":"crossref","first-page":"14406","DOI":"10.1073\/pnas.95.24.14406","volume":"95","author":"HL Sweeney","year":"1998","unstructured":"Sweeney HL, Feng HS, Yang Z, et al. Functional analyses of troponin T mutations that cause hypertrophic cardiomyopathy: insights into disease pathogenesis and troponin function. Proc Natl Acad Sci U S A. 1998;95(24):14406\u201310.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"842_CR40","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0092-8674(01)00242-2","volume":"104","author":"JG Seidman","year":"2001","unstructured":"Seidman JG, Seidman C. The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms. Cell. 2001;104(4):557\u201367.","journal-title":"Cell"},{"issue":"14","key":"842_CR41","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1161\/CIRCULATIONAHA.107.755777","volume":"117","author":"T Tsoutsman","year":"2008","unstructured":"Tsoutsman T, Kelly M, Ng DC, et al. Severe heart failure and early mortality in a double-mutation mouse model of familial hypertrophic cardiomyopathy. Circulation. 2008;117(14):1820\u201331.","journal-title":"Circulation"},{"issue":"16","key":"842_CR42","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1161\/CIRCULATIONAHA.113.001883","volume":"127","author":"P Liang","year":"2013","unstructured":"Liang P, Lan F, Lee AS, et al. Drug screening using a library of human induced pluripotent stem cell-derived cardiomyocytes reveals disease-specific patterns of cardiotoxicity. Circulation. 2013;127(16):1677\u201391.","journal-title":"Circulation"},{"issue":"9","key":"842_CR43","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/nrcardio.2013.105","volume":"10","author":"RE Hershberger","year":"2013","unstructured":"Hershberger RE, Hedges DJ, Morales A. Dilated cardiomyopathy: the complexity of a diverse genetic architecture. Nat Rev Cardiol. 2013;10(9):531\u201347.","journal-title":"Nat Rev Cardiol"},{"issue":"4","key":"842_CR44","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/0002-8703(81)90101-0","volume":"102","author":"WT Dungan","year":"1981","unstructured":"Dungan WT, Garson Jr A, Gillette PC. Arrhythmogenic right ventricular dysplasia: a cause of ventricular tachycardia in children with apparently normal hearts. Am Heart J. 1981;102(4):745\u201350.","journal-title":"Am Heart J"},{"key":"842_CR45","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4137\/CMC.S10940","volume":"7","author":"J Romero","year":"2013","unstructured":"Romero J, Mejia-Lopez E, Manrique C, et al. Arrhythmogenic right ventricular cardiomyopathy (ARVC\/D): a systematic literature review. Clin Med Insights Cardiol. 2013;7:97\u2013114.","journal-title":"Clin Med Insights Cardiol"},{"issue":"7","key":"842_CR46","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1093\/eurheartj\/ehq025","volume":"31","author":"FI Marcus","year":"2010","unstructured":"Marcus FI, McKenna WJ, Sherrill D, et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy\/dysplasia: proposed modification of the Task Force Criteria. Eur Heart J. 2010;31(7):806\u201314.","journal-title":"Eur Heart J"},{"key":"842_CR47","doi-asserted-by":"publisher","unstructured":"Sonoda K, Ohno S, Otuki S, et al. Quantitative analysis of PKP2 and neighbouring genes in a patient with arrhythmogenic right ventricular cardiomyopathy caused by heterozygous PKP2 deletion. Europace. 2016. doi: 10.1093\/europace\/euw038 .","DOI":"10.1093\/europace\/euw038"},{"issue":"17","key":"842_CR48","doi-asserted-by":"crossref","first-page":"6207","DOI":"10.1073\/pnas.0306743102","volume":"102","author":"JR Jones","year":"2005","unstructured":"Jones JR, Barrick C, Kim KA, et al. Deletion of PPARgamma in adipose tissues of mice protects against high fat diet-induced obesity and insulin resistance. Proc Natl Acad Sci U S A. 2005;102(17):6207\u201312.","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Current Cardiology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-017-0842-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11886-017-0842-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-017-0842-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,4]],"date-time":"2020-10-04T01:28:32Z","timestamp":1601774912000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11886-017-0842-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,17]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["842"],"URL":"https:\/\/doi.org\/10.1007\/s11886-017-0842-1","relation":{},"ISSN":["1523-3782","1534-3170"],"issn-type":[{"value":"1523-3782","type":"print"},{"value":"1534-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,17]]},"article-number":"30"}}